<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:type xml:lang="deu">Text</dc:type>
  <dc:type xml:lang="deu">Wissenschaftlicher Artikel</dc:type>
  <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
  <dc:date>2024-09</dc:date>
  <dc:language>eng</dc:language>
  <dc:creator>Amin Sharifan</dc:creator>
  <dc:creator>Sarena Saee</dc:creator>
  <dc:creator>Soheila Saee</dc:creator>
  <dc:description xml:lang="eng">Highlights

Acral lentiginous melanoma has the highest mortality rate among melanoma subtypes.

No studies exist on traditional Chinese medicine for acral lentiginous melanoma.

No studies exist on natural products for acral lentiginous melanoma.

Phytotherapy research for managing acral lentiginous melanoma is warranted.</dc:description>
  <dc:identifier>doi:10.1016/j.prmcm.2024.100503</dc:identifier>
  <dc:publisher>Elsevier</dc:publisher>
  <dc:title xml:lang="eng">A call to action: Addressing the knowledge gap in traditional Chinese medicine&#39;s role against acral lentiginous melanoma</dc:title>
  <dc:format>application/pdf</dc:format>
  <dc:source xml:lang="deu">Pharmacological Research - Modern Chinese Medicine</dc:source>
  <dc:subject xml:lang="eng">Acral lentiginous melanoma</dc:subject>
  <dc:subject xml:lang="eng">Skin neoplasms</dc:subject>
  <dc:subject xml:lang="eng">Sarcoma</dc:subject>
  <dc:type xml:lang="eng">Text</dc:type>
  <dc:type xml:lang="eng">journal article</dc:type>
  <dc:identifier>https://door.donau-uni.ac.at/o:4940</dc:identifier>
</oai_dc:dc>